RENASANT CORP RNST
NYSE · XNYS · stock · State Commercial Banks
Chart by TradingView
4/9
Piotroski F — financial health
—
Altman Z″ — distress risk
43.4%
Dividend payout · moderate
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | — | $181.3M | — | $237.8M | $3.9B |
| 2024 | — | $195.5M | — | $92.8M | $2.7B |
| 2023 | — | $144.7M | — | $126.9M | $2.3B |
| 2022 | — | $166.1M | — | $559.2M | $2.1B |
| 2021 | — | $175.9M | — | $122.1M | $2.2B |
| 2020 | — | $83.7M | — | $54.0M | $2.1B |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Source: SEC EDGAR filings · CIK 0000715072 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.